ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 620256 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 620256; 2) Community: the network communities that were significantly associated with the response to NSC 620256; 3) Molecule: the relationships between components within communities and NSC 620256; 4) MDR: the compounds that were significantly associated with the NSC 620256.

NSC Compound Enrichment Correlation
NSC 107043 Null 0.0430505868034761 -0.19824491
NSC 132277 Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) 0.0430505868034761 0.18950102
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.0430505868034761 -0.20560876
NSC 135077 BERSALDEGENIN 1,3,5-ORTHOACETATE 0.0430505868034761 0.26431238
NSC 165572 Pyrido[3,2-g]quinoline-2,5,8,10(1H,9H)-tetrone, 1,4,6-trimethyl- 0.0430505868034761 0.033442445
NSC 287069 Epicorazine A 0.0430505868034761 -0.098081022
NSC 295499 Camptothecin Derivative 0.0430505868034761 0.56591953
NSC 330507 Tanespimycin 0.0430505868034761 0.0039427825
NSC 357885 Biantrazole 0.0430505868034761 0.59978286
NSC 372146 1,3,5-Triazine, 2-(1-methylethenyl)-2,4-diphenoxy- 0.0430505868034761 -0.064087637
Total:49  Current:42    [First] [Prev] [Next] [Last]